International ME/CFS and FM Awareness Day is May 12: The World Will Know
Did you know that May 12 belongs to us? Lots of us are aware of this. We share the buzz on it amongst ourselves. We add blue ribbons to profile pictures. We raise our voices, join our hands, mount the few podiums available to us and tug at the sleeve of the rest of the world.
Discuss the article on the Forums.

Antiviral activity of diverse classes of broad-acting agents and natural compounds in HHV-6-infected

Discussion in 'Antivirals, Antibiotics and Immune Modulators' started by Ema, Apr 3, 2014.

  1. Ema

    Ema Senior Member

    Messages:
    3,755
    Likes:
    4,715
    Midwest USA
    I have the whole paper if anyone is interested...



    J Clin Virol. 2006 Dec;37 Suppl 1:S69-75.
    Antiviral activity of diverse classes of broad-acting agents and natural compounds in HHV-6-infected lymphoblasts.
    Naesens L1, Bonnafous P, Agut H, De Clercq E.
    Author information

    Abstract
    BACKGROUND:
    HHV-6 replication requires complex and poorly understood interactions between viral and cellular factors.

    OBJECTIVES:
    Several natural compounds or broad-acting pharmacological agents were studied in an attempt to discover new targets for anti-HHV-6 therapy.

    STUDY DESIGN:
    The antiviral activity was determined in human T-lymphoblasts, using HHV-6A (GS)-infected HSB-2 cells, HHV-6B (Z29)-infected MOLT-3 cells and HHV- 6B (HST)-infected MT4 cells. Virus replication was measured by CPE and qPCR assay. Foscarnet was included as the reference compound.

    RESULTS:
    Among the 15 natural compounds tested, only 'red marine algae' (an extract rich in sulfated polysaccharides) exhibited strong activity when added during virus adsorption. Among the broad-acting pharmacological agents, chloroquine, artemisinin, hypericin, ribavirin, resveratrol and glycyrrhizic acid were all inactive. Amantadine produced a reproducible inhibition of HHV-6 replication, albeit at relatively high concentrations. Except for lamotrigine, which was moderately active against HHV-6B, several antiepileptic drugs were shown to have no activity. We included several compounds which we previously described as potent HHV-6 inhibitors, i.e., the non-nucleoside inhibitor CMV423 and the acyclic nucleoside phosphonate analogues cidofovir and 9-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]-3-deazaadenine. The latter compound exhibited remarkable anti-HHV-6 activity.

    CONCLUSION:
    Further optimization of compounds belonging to diverse classes of antiherpetic agents, for their specific action against HHV-6, is warranted.
     
    Iquitos, heapsreal and SOC like this.

See more popular forum discussions.

Share This Page